ESC2018丨盛会在即！四大指南、最新研究，您想知道的都在这里（附最终日程下载）

本次大会将有哪些值得关注的亮点和重点日程，一起来看看：

2018 ESC/ESH Guidelines on Arterial Hypertension

2018 ESC/ESH 动脉高血压指南

2018 ESC Guidelines for CVD during Pregnancy

2018 ESC妊娠期心血管疾病指南

2018 ESC/EACTS Guidelines on Myocardial Revascularization

2018 ESC / EACTS心肌血运重建指南

2018 ESC Guidelines for the diagnosis and management of Syncope and the expert consensus document

2018 ESC晕厥诊断和管理指南及专家共识文件

8月26日，由欧洲心脏病学会（ESC）/美国心脏病学学会（ACC）/美国心脏协会（AHA）/世界心脏联盟（WHF）共同制定的“第四次全球心肌梗死定义”将在慕尼黑主会场公布。

MARINER - Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk

MARINER - 利伐沙班 vs. 安慰剂在减少出院后患者静脉血栓栓塞风险中的不良事件评估

CAMELLIA-TIMI 61 - Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61

CAMELLIA-TIMI 61 - 氯卡色林在超重和肥胖患者心肌梗死溶栓治疗中的心血管和代谢作用

ARRIVE - Aspirin to Reduce Risk of Initial Vascular Events

ARRIVE - 阿司匹林可降低首次血管事件风险

ASCEND - A randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes

ASCEND -一项纳入15 480例糖尿病患者，比较阿司匹林与安慰剂在心血管疾病一级预防中的随机试验

ASCEND - A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 people with diabetes

ASCEND - 一项纳入15 480例糖尿病患者，比较ω-3脂肪酸（鱼油）与安慰剂在心血管一级预防中的随机试验

ART - Randomised comparison of bilateral versus single internal thoracic coronary artery bypass graft surgery: effects on mortality at ten years follow-up in the Arterial Revascularisation Trial    

ART -一项比较双侧与单侧胸内冠状动脉旁路移植术对动脉血运重建术后患者10年死亡率影响的随机对照试验

ATTR-ACT - Efficacy and Safety of Tafamidis in Transthyretin Amyloid Cardiomyopathy

ATTR-ACT - Tafamidis在转甲状腺素蛋白淀粉样变性心肌病中的疗效和安全性

COMMANDER HF - Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure

COMMANDER HF - 一项比较利伐沙班与安慰剂在失代偿性心力衰竭发病患者心力衰竭和严重冠状动脉疾病治疗中的随机试验

MITRA.fr study - A randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation and reduced left ventricular ejection fraction

MITRA.fr研究 - 一项评估经皮二尖瓣修复术在继发性二尖瓣关闭不全和左心室射血分数降低患者治疗中有效性的随机对照试验

GLOBAL LEADERS TRIAL- A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy

GLOBAL LEADERS TRIAL - 24个月替格瑞洛和1个月阿司匹林 vs. 12个月双联抗血小板治疗后予阿司匹林单药治疗的随机对照试验

PURE - Association of dietary quality and risk of cardiovascular disease and mortality in more than 218,000 people from over 50 countries

PURE- 来自50多个国家的21.8万多人膳食质量与心血管疾病风险和死亡率关系的研究

FREED - Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy

FREED - Febuxostat用于脑和心血管事件预防的研究

BASKET-SMALL 2 - Drug-Coated Balloons vs. Drug- Eluting Stents in Small Vessel Interventions

BASKET-SMALL 2 - 药物涂层球囊 vs. 药物洗脱支架在小血管介入治疗中的比较

VERDICT - Early versus deferred invasive examination and treatment of patients with Non-ST-segment elevation acute coronary syndrome

VERDICT - 非ST段抬高型急性冠状动脉综合征患者的早期vs. 延期侵入性检查和治疗

High-STEACS - High-Sensitivity Troponin in the Evaluation of patients with Acute Coronary Syndrome

High-STEACS - 高敏感肌钙蛋白在急性冠状动脉综合征患者评估中的应用

POET - Partial oral treatment of left-sided infectious endocarditis

POET - 左侧感染性心内膜炎的部分口服治疗

AIMS - Aortic Irbesartan Marfan Study

AIMS - 主动脉厄贝沙坦马凡研究

COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban

COMPASS试验 - 利伐沙班治疗血管疾病患者的出血和癌症风险

CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality

CANTOS - 白细胞介素-6信号通路的调控与动脉粥样硬化事件和死亡的发生率

CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation

CABANA试验 - 导管消融术 vs. 抗心律失常药物治疗心房颤动复发性房性心律失常

ASCOT Legacy study - Longterm impact of the of BP and Lipid lowering treatment in hypertensive patients

ASCOT Legacy study  - 血压和降脂治疗对高血压患者的长期影响

ASCT-1 - 15-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis: extended post-trial follow-up of patients in the first Asymptomatic Carotid Surgery Trial

ASCT-1 - 颈动脉内膜切除术治疗无症状性狭窄后的卒中预防15年：首次无症状颈动脉手术试验中患者的术后随访时间延长

TRICS III - Restrictive versus liberal red blood cell transfusion in cardiac surgery: 6 month data

TRICS III - 心脏手术中限制性与自由红细胞输血：6个月数据

The ACCA-EAPCI registry on ST-elevation myocardial infarction of the European Society of Cardiology (ESC)

ACCA-EAPCI欧洲心脏病学会（ESC）ST段抬高心肌梗死注册研究

EORP-AF General Long-Term Registry - Antithrombotic Drugs and Outcomes at 1-year Follow-Up in Patients with Atrial Fibrillation

EORP-AF  - 抗血栓药物和心房颤动患者的1年随访结果

EORP-AF General Long-Term and Euro Heart Survey AF Registries - Changing Epidemiology of Lone Atrial Fibrillation and Oral Anticoagulant Prescriptions over 15 years in Europe

EORP-AF  - 欧洲15年期间心房颤动和口服抗凝药物处方的流行病学改变

ELECTRa registry sub-analysis - Systemic vs. local CIED infection, not just a question of time

ELECTRa注册研究亚组分析 - 系统性vs.局部CIED感染，不仅仅是时间问题

SWEDEHEART - No changes in survival after acute myocardial infarction in the last decade - new data

SWEDEHEART - 近十年的最新数据表明，急性心肌梗死后患者生存率没有变化

The FAST-MI programme - French registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction

FAST-MI项目- 关于急性ST段抬高和非ST段抬高心肌梗死的法国注册研究

EUROASPIRE - Time trends in lifestyle, cardiovascular risk factors, and therapeutic management in patients with coronary disease in Europe: A comparison of EUROASPIRE IV and V surveys over 5 years in 21 countries

EUROASPIRE - 欧洲冠心病患者的生活方式，心血管危险因素和治疗管理的时间趋势：21个国家5年内EUROASPIRE IV和V调查的比较

EORP VHD II registry - Contemporary mangement of heart valve disease

EORP VHD II registry - 目前心脏瓣膜病的管理

VISION Study - Frequency, Causes, and Timing of 30-day Mortality After Noncardiac Surgery: Analysis of the Vascular Events in Noncardiac Surgery Patients (VISION)

VISION 研究 - 非心脏手术后30天死亡率的频率，原因和时机：非心脏手术患者的血管事件分析

CLARIFY - A simple risk model to predict cardiovascular death or myocardial infarction in patients with stable coronary artery disease

CLARIFY - 一种简便的风险模型，用于预测稳定性冠心病患者的心血管死亡或心肌梗死

GARFIELD-AF prospective registry - Comparative effectiveness of oral anticoagulants in everyday practice

GARFIELD-AF前瞻性注册研究 - 口服抗凝剂在日常实践中的疗效比较

GARFIELD-AF prospective registry - Adverse one-year outcomes for patients newly treated with oral anticoagulants plus antiplatelet therapy after a diagnosis of atrial fibrillation

GARFIELD-AF前瞻性注册研究 -心房颤动诊断后给予口服抗凝剂加抗血小板治疗的患者一年不良结局

ROPAC - Pregnancy in women with cardiovascular disease: trends in outcome from 10 years ESC Registry Of Pregnancy And Cardiac disease

ROPAC - 患有心血管疾病的妊娠女性：10年来ESC妊娠和心脏病登记结果趋势

COMPASS-MI - Application of High-Sensitivity Troponin in Suspected Myocardial Infarction

COMPASS-MI - 高敏肌钙蛋白在疑似心肌梗死中的应用

A naturally randomized trial evaluating the potential clinical benefit of therapies that reduce triglyceride-rich lipoproteins on the risk of coronary heart disease

一项自然随机试验，评估降低富含甘油三酯的脂蛋白以减少冠心病风险的治疗方法的潜在临床获益

CRISP-CT study - Non-invasive detection of coronary inflammation by computed tomography analysis of pericoronary fat enhances cardiovascular risk prediction in 3912 individuals

CRISP-CT研究 - 通过冠状动脉脂肪的计算机断层扫描分析对冠状动脉炎症进行非侵入性检测可增强3912例个体的心血管风险预测

LRT - Transcatheter Aortic Valve Replacement For Patients With Severe Aortic Stenosis Who Are At Low Risk For Mortality: Results From The Prospective Multicenter LRT Clinical Trial

LRT - 经导管主动脉瓣膜置换术治疗死亡风险较低的重度主动脉瓣狭窄患者：前瞻性多中心LRT临床试验结果

GARY - Patients at low surgical risk undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and one-year results from the German Aortic Valve Registry (GARY)

GARY -低手术风险患者接受孤立介入或外科主动脉瓣植入术：来自德国主动脉瓣注册登记处（GARY）的住院数据和1年结果

TAVI-PM - Post-mortem study on the durability of TAVI

TAVI-PM - TAVI耐用性的尸检研究

FRANCE-2 Registry - 5-Year Clinical Outcome and Valve Durability after Transcatheter Aortic Valve Implantation in High-Risk Patients

FRANCE-2注册研究 - 高风险患者经导管主动脉瓣植入术后5年临床结局和瓣膜耐用性